Takeda, Portal Instruments Partner in Developing Needle-free Drug Delivery Service

Takeda, Portal Instruments Partner in Developing Needle-free Drug Delivery Service
Takeda Pharmaceutical and Portal Instruments will collaborate to develop and commercialize Portal’s needle-free drug delivery service for potential use with Takeda’s investigational and approved therapies, including treatments for ulcerative colitis (UC) and Crohn’s disease. The needle-free device could potentially be used across a range of biologic medicines that currently require administration through an injection and

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *